Familial Dilated Cardiomyopathy Secondary to Dystrophin Splice Site Mutation

Journal of Cardiac Failure

Volumn 16, Issue 3, 2010, Pages 194-199

  Obler, Dita ^a   Wu, Bai Lin ^a   Lip, Va ^a   Estrella, Elicia ^a   Keck, Sally ^b   Haggan, Coral ^b   Semigran, Marc ^b   Smoot, Leslie B ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

CPK; Family history; genetics; myocarditis

Indexed keywords

DYSTROPHIN;

ADULT; ARTICLE; CARDIOMYOPATHY; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; FAMILIAL DISEASE; FAMILY HISTORY; FEMALE; GENE MUTATION; HEART DEATH; HEART TRANSPLANTATION; HUMAN; MALE; MUSCLE WEAKNESS; PEDIGREE; PRIORITY JOURNAL;

ADULT; CARDIOMYOPATHY, DILATED; CHILD; DYSTROPHIN-ASSOCIATED PROTEINS; EXONS; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GENOTYPE; HETEROZYGOTE; HUMANS; MALE; PEDIGREE; POINT MUTATION; PROGNOSIS; RISK ASSESSMENT; RNA SPLICING; SURVIVAL RATE;

EID: 77449155277     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2009.11.009     Document Type: Article

References (26)

1. Lipshultz S.E., Sleeper L.A., Towbin J.A., Lowe A.M., Orav E.J., Cox G.F., et al. The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med 348 (2003) 1647-1655
2. Manolio T.A., Baughman K.L., Rodeheffer R., Pearson T.A., Bristow J.D., Michels V.V., et al. Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung, and Blood Institute workshop). Am J Cardiol 69 (1992) 1458-1466
3. Hershberger R.E., Lindenfeld J., Mestroni L., Seidman C.E., Taylor M.R., and Towbin J.A. Genetic evaluation of cardiomyopathy-a Heart Failure Society of America practice guideline. J Card Fail 15 (2009) 83-97
4. Hershberger RE, Kushner JD, Parks SB. Gene reviews: dilated cardiomyopathy overview. Last revision: March 19, 2009 [May 28, 2009]; Available from: http://www.genetests.org/servlet/access?db=geneclinics&site=gt&id=8888891&key=clzhsDT00Sb2H&gry=&fcn=y&fw=CL0C&filename=/profiles/dcm-ov/index.html. Accessed December 14, 2009.
5. Baig M.K., Goldman J.H., Caforio A.L., Coonar A.S., Keeling P.J., and McKenna W.J. Familial dilated cardiomyopathy: cardiac abnormalities are common in asymptomatic relatives and may represent early disease. J Am Coll Cardiol 31 (1998) 195-201
6. Hanson E.L., and Hershberger R.E. Genetic counseling and screening issues in familial dilated cardiomyopathy. J Genet Couns 10 (2001) 397-415
7. Burkett E.L., and Hershberger R.E. Clinical and genetic issues in familial dilated cardiomyopathy. J Am Coll Cardiol 45 (2005) 969-981
8. Feng J., Yan J.Y., Buzin C.H., Sommer S.S., and Towbin J.A. Comprehensive mutation scanning of the dystrophin gene in patients with nonsyndromic X-linked dilated cardiomyopathy. J Am Coll Cardiol 40 (2002) 1120-1124
9. Cohen N., and Muntoni F. Multiple pathogenetic mechanisms in X linked dilated cardiomyopathy. Heart 90 (2004) 835-841
10. Bennett R.R., den Dunnen J., O'Brien K.F., Darras B.T., and Kunkel L.M. Detection of mutations in the dystrophin gene via automated DHPLC screening and direct sequencing. BMC Genet 2 (2001) 17
11. Milasin J., Muntoni F., Severini G.M., Bartoloni L., Vatta M., Krajinovic M., et al. A point mutation in the 5' splice site of the dystrophin gene first intron responsible for X-linked dilated cardiomyopathy. Hum Mol Genet 5 (1996) 73-79
12. Kimura S., Ikezawa M., Ozasa S., Ito K., Ueno H., Yoshioka K., et al. Novel mutation in splicing donor of dystrophin gene first exon in a patient with dilated cardiomyopathy but no clinical signs of skeletal myopathy. J Child Neurol 22 (2007) 901-906
13. Arbustini E., Diegoli M., Morbini P., Dal Bello B., Banchieri N., Pilotto A., et al. Prevalence and characteristics of dystrophin defects in adult male patients with dilated cardiomyopathy. J Am Coll Cardiol 35 (2000) 1760-1768
14. Feng J., Yan J., Buzin C.H., Towbin J.A., and Sommer S.S. Mutations in the dystrophin gene are associated with sporadic dilated cardiomyopathy. Mol Genet Metab 77 (2002) 119-126
15. Politano L., Nigro V., Nigro G., Petretta V.R., Passamano L., Papparella S., et al. Development of cardiomyopathy in female carriers of Duchenne and Becker muscular dystrophies. JAMA 275 (1996) 1335-1338
16. Towbin J.A., Hejtmancik J.F., Brink P., Gelb B., Zhu X.M., Chamberlain J.S., et al. X-linked dilated cardiomyopathy. Molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus. Circulation 87 (1993) 1854-1865
17. Muntoni F., Cau M., Ganau A., Congiu R., Arvedi G., Mateddu A., et al. Brief report: deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy. N Engl J Med 329 (1993) 921-925
18. Muntoni F., Wilson L., Marrosu G., Marrosu M.G., Cianchetti C., Mestroni L., et al. A mutation in the dystrophin gene selectively affecting dystrophin expression in the heart. J Clin Invest 96 (1995) 693-699
19. Hoffman E.P., Fischbeck K.H., Brown R.H., Johnson M., Medori R., Loike J.D., et al. Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne's or Becker's muscular dystrophy. N Engl J Med 318 (1988) 1363-1368
20. Muntoni F., Torelli S., and Ferlini A. Dystrophin and mutations: one gene, several proteins, multiple phenotypes. Lancet Neurol 2 (2003) 731-740
21. Bastianutto C., Bestard J.A., Lahnakoski K., Broere D., De Visser M., Zaccolo M., et al. Dystrophin muscle enhancer 1 is implicated in the activation of non-muscle isoforms in the skeletal muscle of patients with X-linked dilated cardiomyopathy. Hum Mol Genet 10 (2001) 2627-2635
22. Ferlini A., Sewry C., Melis M.A., Mateddu A., and Muntoni F. X-linked dilated cardiomyopathy and the dystrophin gene. Neuromuscul Disord 9 (1999) 339-346
23. Jefferies J.L., Eidem B.W., Belmont J.W., Craigen W.J., Ware S.M., Fernbach S.D., et al. Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy. Circulation 112 (2005) 2799-2804
24. Bostick B., Yue Y., Long C., Marschalk N., Fine D.M., Chen J., et al. Cardiac expression of a mini-dystrophin that normalizes skeletal muscle force only partially restores heart function in aged Mdx mice. Mol Ther 17 (2009) 253-261
25. McNally E.M. New approaches in the therapy of cardiomyopathy in muscular dystrophy. Annu Rev Med 58 (2007) 75-88
26. Townsend D., Yasuda S., Li S., Chamberlain J.S., and Metzger J.M. Emergent dilated cardiomyopathy caused by targeted repair of dystrophic skeletal muscle. Mol Ther 16 (2008) 832-835